Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Published on Jan 1, 2007in European Journal of Vascular and Endovascular Surgery5.328
· DOI :10.1016/J.JVS.2006.12.037
Lars Norgren61
Estimated H-index: 61
,
William R. Hiatt96
Estimated H-index: 96
(University of Colorado Denver)
+ 3 AuthorsF. G. R. Fowkes59
Estimated H-index: 59
Sources
Abstract
The Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC) was published in January 2000 as a result of cooperation between fourteen medical and surgical vascular, cardiovascular, vascular radiology and cardiology societies in Europe and North America. This comprehensive document had a major impact on vascular care amongst specialists. In subsequent years, the field has progressed with the publication of the CoCaLis document and the American College of Cardiology/American Heart Association Guidelines for the Management of Peripheral Arterial Disease. Aiming to continue to reach a readership of vascular specialists, but also physicians in primary health care who see patients with peripheral arterial disease (PAD), another consensus process was initiated during 2004. This new consensus document has been developed with a broader international representation, including Europe, North America, Asia, Africa and Australia, and with a much larger distribution and dissemination of the information. The goals of this new consensus are to provide an abbreviated document (compared with the publication in 2000), to focus on key aspects of diagnosis and management, and to update the information based on new publications and the newer guidelines, but not to add an extensive list of references. Unreferenced statements are, therefore, to be found, provided they are recognized as common practice by the authors, with existing evidence. The recommendations are graded according to levels of evidence. It should also be emphasized that good practice is based on a combination of the scientific evidence described below, patients’ preferences, and local availability of facilities and trained professionals. Good practice also includes appropriate specialist referral.
Download
📖 Papers frequently viewed together
474 Citations
716 Citations
200723.60Circulation
14 Authors (Hans Krankenberg, ..., Thomas Zeller)
433 Citations
References232
Newest
#1Rachel Bedenis (Edin.: University of Edinburgh)H-Index: 4
#2Anne Lethaby (University of Auckland)H-Index: 39
Last. Martin H. Prins (UM: Maastricht University)H-Index: 112
view all 5 authors...
Background Peripheral arterial disease (PAD) may cause occlusions (blockages) in the main arteries of lower limbs. One treatment option is bypass surgery using autologous (the patient's own tissue) vein graft or prosthetic (artificial) graft. A number of factors influence occlusion rates in these patients, including the material used. To prevent graft occlusion patients are usually treated with antiplatelet, antithrombotic drugs, or a combination of both. Objectives To determine the effects of a...
115 CitationsSource
#1Benilde Cosmi (UNIBO: University of Bologna)H-Index: 42
#2Eleonora ContiH-Index: 6
Last. Sergio CoccheriH-Index: 27
view all 3 authors...
Background Anticoagulant treatment for intermittent claudication might improve functional capacity and prevent acute cardiovascular complications caused by peripheral obstructive arterial disease. This is an update of the review first published in 2001. Objectives To assess the effects of anticoagulant drugs (heparin, low molecular weight heparin (LMWH) and oral anticoagulants) in patients with intermittent claudication (Fontaine stage II) in terms of improving walking capacity (pain-free walkin...
31 CitationsSource
#1David C Berridge (LGI: Leeds General Infirmary)H-Index: 6
#2David KesselH-Index: 25
Last. Iain Robertson (Gartnavel General Hospital)H-Index: 7
view all 3 authors...
Background Peripheral arterial thrombolysis is technique used in the management of peripheral arterial ischaemia. Much is known about the indications, risks and benefits of thrombolysis. However, it is not known whether thrombolysis works better than surgery in the initial treatment of acute limb ischaemia. Objectives To determine the preferred initial treatment, surgery or thrombolysis, for acute limb ischaemia. Search methods For this update the Cochrane Peripheral Vascular Diseases Group Tria...
93 CitationsSource
#1Tine De Backer (Ghent University Hospital)H-Index: 20
#2Robert Vander Stichele (UGent: Ghent University)H-Index: 41
Background Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease. However, its clinical efficacy for IC has not yet been critically examined. Objectives To evaluate the available evidence on the efficacy of buflomedil for IC. Search strategy We searched the specialized trials register of the Cochrane Peripheral Vascular Disea...
33 CitationsSource
#1Dirk T. Ubbink (UvA: University of Amsterdam)H-Index: 55
#2Hester Vermeulen (UvA: University of Amsterdam)H-Index: 32
Background Patients suffering from inoperable chronic critical leg ischaemia (NR-CCLI), face amputation of the leg. Spinal cord stimulation (SCS) has been proposed as a helpful treatment in addition to standard conservative treatment. Objectives To find evidence for an improvement of limb salvage, pain relief and clinical situation using SCS compared to conservative treatment alone. Search strategy We searched the Cochrane Peripheral Vascular Diseases Group's Specialised Register, (last searched...
113 CitationsSource
#1F.B. Smith (Edin.: University of Edinburgh)H-Index: 25
#2Andrew W. BradburyH-Index: 67
Last. Gerry Fowkes (Edin.: University of Edinburgh)H-Index: 16
view all 3 authors...
BACKGROUND: Peripheral arterial disease affects 5% of men and women by late middle age. In approximately 25% of those affected the condition will progress to critical limb ischaemia (rest pain, ulceration and gangrene) within five years. The vasoactive drug naftidrofuryl is a serotononergic receptor antagonist which may be beneficial in the treatment of severe lower limb disease such as critical limb ischaemia. OBJECTIVES: To determine whether the vasoactive drug, naftidrofuryl, when administere...
16 CitationsSource
#1Evan C. Lipsitz (Albert Einstein College of Medicine)H-Index: 31
#2Soo Joong Kim (RU: Rutgers University)H-Index: 11
The management of elderly patients with peripheral arterial disease requires a multidisciplinary and individualized approach, especially for patients requiring intervention and for those on antithrombotic therapy. Communication between the patient's primary physician, consulting medical specialists, and vascular surgeon is essential because all may contribute synergistically to deliver optimal care to the patient. This article reviews the pathophysiology of peripheral arterial disease and data r...
9 CitationsSource
#1Curt Diehm (Heidelberg University)H-Index: 19
#2Abri OH-Index: 2
Last. Marshall MH-Index: 2
view all 10 authors...
: The effectiveness of iloprost, a prostacyclin derivative, was assessed in a placebo-controlled multicentre trial on 101 patients with chronic arterial disease, stage IV. All patients were on a basic local treatment, 53 randomly being assigned to the iloprost group, 48 to the placebo one. Both groups received identical saline infusions, one with the other without iloprost. Infusions were given on 28 consecutive days, iloprost being added at a dose of up to 2 ng/kg.min over six hours. At the end...
40 CitationsSource
54 CitationsSource
2 CitationsSource
Cited By5912
Newest
Last. Filippo CademartiriH-Index: 77
view all 6 authors...
Source
#1Mariel RiveroH-Index: 5
#2Hasan H. DosluogluH-Index: 23
Abstract null null Endovascular treatment of complex aortoiliac occlusive disease had been adopted widely and now rivals open reconstruction. The most important aspect of aortoiliac revascularization is to anticipate and to avoid complications via careful preoperative planning. However, despite appropriate planning, complications will occur and, in that event, timely and appropriate management can minimize adverse outcomes.
Source
#1James F. McKinseyH-Index: 44
#2Reid A. RavinH-Index: 6
Abstract null null There have been dramatic improvements in the treatment of femoropopliteal disease for arterial occlusive disease. This chapter details current endovascular interventional therapy for this anatomic segment. We discuss methods for crossing lesions antegrade and retrograde as well as re-entry catheters. Standard treatment modalities, including drug-coated balloon angioplasty and atherectomy, are discussed in detail, as well as newer investigational techniques including the DETOUR...
Source
#1Jan SkóraH-Index: 7
#2Maciej AntkiewiczH-Index: 1
Last. Piotr BarćH-Index: 6
view all 7 authors...
Source
Source
#1Prakash Krishnan (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 23
#2Arthur Tarricone (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 5
Last. Samin K. Sharma (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 67
view all 9 authors...
We assessed the clinical outcomes of patients with critical limb-threatening ischemia (CLTI) who underwent interwoven nitinol stent (Supera) implantation for significant stenoses of the femoropopli...
Source
#1Shirling Tsai (UTSW: University of Texas Southwestern Medical Center)H-Index: 16
#2Yulun Liu (UTSW: University of Texas Southwestern Medical Center)
Last. Subhash Banerjee (UTSW: University of Texas Southwestern Medical Center)H-Index: 56
view all 6 authors...
Background: The effect of pharmacologic agents in improving walking and quality of life measures in patients with intermittent claudication (IC) is variable. The objective of this study was to investigate the effect of the novel antithrombotic vorapaxar on symptom status in patients with IC. Methods: The study was a multicenter, randomized, placebo-controlled trial wherein patients with IC were treated with either vorapaxar or placebo in addition to a home exercise program for 6 months. Walking ...
Source
#1Musa Güneş (Karabük University)
#2Tarik Ozmen (Karabük University)H-Index: 5
Last. Tugba Morali Guler (Karabük University)H-Index: 2
view all 3 authors...
Background The effect of lumbar spinal stenosis (LSS) and peripheral vascular disease (PVD), which occurs with similar degenerative conditions, when seen together, has not been studied. The aim of this study is to examine and compare the relationship between pain, balance, disability, fear of falling, and kinesiophobia in LSS patients with intermittent vascular claudication (IVC). Methods Seventy-two patients diagnosed with LSS using magnetic resonance imaging participated in this study. Thirty-...
Source
#1Isaac N. Naazie (UCSD: University of California, San Diego)H-Index: 3
#2Sina Zarrintan (Tabriz University of Medical Sciences)H-Index: 14
Last. Mahmoud B. Malas (UCSD: University of California, San Diego)H-Index: 32
view all 6 authors...
Abstract null null Objective null Combined suprainguinal and infrainguinal revascularization is sometimes necessary in the treatment of patients with chronic limb-threatening ischemia (CLTI). However, data on outcomes of concomitant revascularization procedures are lacking. We studied the outcomes of patients with CLTI who underwent suprainguinal bypass (SIB) alone, SIB with concomitant infrainguinal bypass (IIB), and SIB with concomitant infrainguinal peripheral endovascular intervention (IIPVI...
Source
Abstract null null Introduction null The prevalence and incidence of peripheral arterial disease (PAD) are increasing in the general population. There are limited data on the epidemiology of Chronic Limb-Threatening Ischemia (CLTI), which likely represents null null In the last years, several techniques have been developed to overcome limitations of standard antegrade endoluminal or subintimal approaches, if they fails. null Advanced Techniques null Subintimal techniques null Crush balloon, Para...
Source